Subscribe to Seeking Alpha feed
https://seekingalpha.com
URL: https://seekingalpha.com
Updated: 34 min 8 sec ago

Voya Target Retirement Trust Q4 2025 Commentary

Tue, 02/24/2026 - 01:25

ABB: Powering AI's Buildout, But With Little Room For Error

Tue, 02/24/2026 - 01:23

Shinhan Financial: Eyes On Shareholder Returns And ROE Target

Tue, 02/24/2026 - 01:12

T-REX announces liquidation of ARMU and ETQ ETFs

Tue, 02/24/2026 - 01:10

Hartford AAA CLO ETF Q4 2025 Commentary

Tue, 02/24/2026 - 01:10

Backblaze outlines $14B neocloud opportunity and projects 20% B2 growth for 2026 amid AI-driven expansion

Tue, 02/24/2026 - 01:05

Cannae outlines accelerated portfolio transformation and 80% stadium capacity expansion, prioritizing sports and entertainment assets

Tue, 02/24/2026 - 01:05

Vir Biotechnology outlines $1.7B Astellas collaboration and anticipates cash runway into Q2 2028 as VIR-5500 advances

Tue, 02/24/2026 - 01:05

Apple more confident in Mac Mini Houston plans than Mac Pro Austin; moves to expand U.S. assembly and chip production

Tue, 02/24/2026 - 01:00

Vir Biotechnology, Inc. 2025 Q4 - Results - Earnings Call Presentation

Tue, 02/24/2026 - 00:55

Amazon: How I Learned To Stop Worrying And Love The CapEx

Tue, 02/24/2026 - 00:54

Bayer sues Johnson & Johnson over prostate cancer drug claims

Tue, 02/24/2026 - 00:54

BNY Mellon California AMT-Free Municipal Bond Fund Q4 2025 Commentary

Tue, 02/24/2026 - 00:45

Lendlease Group 2026 Q2 - Results - Earnings Call Presentation

Tue, 02/24/2026 - 00:31

Solvay GAAP EPS of €0.13, revenue of €995M; introduces FY26 outlook

Tue, 02/24/2026 - 00:31

Allison Transmission Holdings, Inc. 2025 Q4 - Results - Earnings Call Presentation

Tue, 02/24/2026 - 00:30

Pliant Therapeutics: A Reverse Arbitrage Opportunity Driven By A Poison Pill Expiration

Tue, 02/24/2026 - 00:28

Standard Chartered Non-GAAP EPS of $0.37, net interest income of $1.5B; introduces FY26 outlook

Tue, 02/24/2026 - 00:28

Invesco Growth And Income Fund Q4 2025 Commentary

Tue, 02/24/2026 - 00:25

Fresenius Medical Care Non-GAAP EPS of Є1.44, revenue of Є5.07B; introduces FY26 and long-term outlook

Tue, 02/24/2026 - 00:23

Pages